Aromasin^®

Aromasin^® is a breast cancer hormonal therapy that works to prevent cancerous cells from getting the estrogen they need in order to grow and reproduce. It is indicated as an adjuvant treatment (following surgery, chemotherapy or radiation) for estrogen receptor-positive, early stage breast cancer in postmenopausal women.

Aromasin^® is approved for use following two to three years of tamoxifen treatment, at which time patients should no longer undergo tamoxifen therapy. During early breast cancer stages, Aromasin^® treatment should continue for two to three years following discontinuation of tamoxifen therapy. Clinical studies have shown that taking Aromasin^® after tamoxifen may further reduce the chance of recurring breast cancer.

At Cancer Treatment Centers of America (CTCA), your team of cancer experts will discuss Aromasin^® as a possible treatment option for your breast cancer. Using a powerful combination of traditional and innovative cancer therapies, we ensure that you are well-informed regarding possible therapies and are comfortable with all decisions made regarding your cancer treatment.

Breast cancer patients undergoing Aromasin^® treatment may experience the following serious side effects:

• Allergic reactions (difficulty breathing, closing of the throat, swelling of the lips, tongue or face, or hives).

If you experience any of these side effects following Aromasin^® treatment, contact your doctor immediately.

Less serious side effects of Aromasin^® treatment include the following:

• Hot flashes
• Fatigue
• Insomnia
• Increased sweating
• Swelling
• Water retention
• Depression or anxiety
• Flu-like symptoms
• Abdominal pain
• A change in appetite
• Headache or dizziness
• Nausea
• Vomiting
• Diarrhea or constipation
• Shortness of breath
• Increased coughing

Please note that this list is not all inclusive, and that patients may experience other side effects during Aromasin^® treatment.

At Cancer Treatment Centers of America (CTCA), your team of cancer specialists will work closely with you to develop your treatment plan. Together, you’ll create and implement a personalized plan for your breast cancer treatment.

In addition to our welcoming and nurturing environment, we offer advanced breast cancer treatment options which are hard to find at other medical centers. Our goal is to understand and cater to your needs, ensure you are well informed during every step of your breast cancer treatment, and improve your overall quality of life during this difficult time.

Aromasin^® is indicated for the treatment of postmenopausal women with estrogen receptor-positive (ER+) early stage breast cancer.

Helping to stop the production of estrogen in postmenopausal women, Aromasin^® attempts to lessen the risk of estrogen-dependent tumor growth. Aromasin^® works differently than tamoxifen. Rather than preventing estrogen from connecting itself to breast cancer cells, Aromasin^® reduces estrogen levels in postmenopausal women by up to 98 percent.

At Cancer Treatment Centers of America (CTCA), we use a powerful blend of traditional and innovative breast cancer treatment methods, along with supportive/complementary therapies. You and your team of cancer specialists will work together to develop a personalized plan of treatment that is right for you.

Chat now with an Oncology Information Specialist to learn more about our individualized approach to breast cancer treatment.